436100-81-1Relevant articles and documents
Novel method and use
-
, (2008/06/13)
The invention relates to a method of antagonizing GLP-1 activity in a mammalian patient, comprising administering to said patient an effective amount of a compound of the general formula I: wherein R1 and R2 independently of each other are C1-4-alkyl, R3 is halogen, hydroxy, C1-4-alkoxy or trifluoromethoxy, R4 is hydrogen, hydroxy or C1-4-alkoxy, or a pharmacologically acceptable salt thereof. The invention also relates to a pharmaceutical composition comprising a compound of formula I.